Billing Codes

SJ434

Xience PRIME LL Everolimus Eluting Coronary Stent; Xience PRIME Everolimus Eluting Coronary Stent; Xience PRIME SV Everolimus Eluting Coronary Stent

Current benefit
$1095.00
Last updated
March 2021
Category
08 - Cardiac
08.12 - Coronary Stents
Status
Unchanged
Size / specification

XIENCE PRIME LL 2.50; 2.75; 3.00; 3.50; 4.0 x 33MM; XIENCE PRIME LL 2.50; 2.75; 3.00; 3.50; 4.0 x 38MM; XIENCE PRIME SV 2.25 x 08; 12; 15; 18; 23; 28MM; XIENCE PRIME 2.50 x 08; 12; 15; 18; 23; 28MM; XIENCE PRIME 2.75 x 08; 12; 15; 18; 23; 28MM; XIENCE PRIME 3.00 x 08; 12; 15; 18; 23; 28MM; XIENCE PRIME 3.50 x 08; 12; 15; 18; 23; 28MM; XIENCE PRIME 4.00 x 08; 12; 15; 18; 23; 28MM

Description

Coronary Artery Stent, Drug Eluting

TGA safety record
Not yet checked against TGA's safety database
Check on TGA ↗

Count and link only, sourced from the TGA's Database of Recalls, Product Alerts and Product Corrections. "Market actions" includes recalls, product alerts and product corrections — full detail stays on the TGA's own site.

Benefit history

No recorded changes yet — history accumulates with each release.

Data sourced from Australian Government publications · Not an official government service